About: Max Peters

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Max Peters Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq)
rdfs:label	Max Peters (en) Max Peters (es) Max Peters (fr) Max Peters (nl) Max Peters (sl) Max Peters (ast)
skos:prefLabel	Max Peters (en) Max Peters (es) Max Peters (fr) Max Peters (nl) Max Peters (sl) Max Peters (ast)
name	Max Peters (en) Max Peters (es) Max Peters (fr) Max Peters (nl) Max Peters (sl) Max Peters (ast)
given name	wds:Q40309011-622282FD-05AD-44E0-858D-4C2777CECE5F
given name	Max
instance of	wds:Q40309011-364D694E-B82A-446C-B05C-45E3C46B549B
instance of	Homo sapiens
occupation	wds:Q40309011-0541EC40-C975-4A3C-A071-4F5D04B108C8
employer	wds:Q40309011-63201245-02CD-4E60-ADAA-A42DE47CD595 wds:Q40309011-A9A03474-3D05-4C55-AF86-08D9E3BC62EF
sex or gender	wds:Q40309011-F8B46C62-5240-4D37-A72C-66C86D12B8A6
ISNI	wds:Q40309011-72C0820B-E92C-41C3-BB4C-287145A3FBF4
VIAF ID	wds:Q40309011-C94C0646-94F6-4B7F-80BE-C11B527106DA
family name	wds:Q40309011-D8512872-3414-4FF1-BD63-135633CCC613
WorldCat Identities ID (superseded)	wds:Q40309011-F1417887-4CB8-4DA1-9102-D41BD52D7B8E
VIAF ID	http://viaf.org/viaf/751149066712065601360
occupation	researcher
employer	Utrecht University University Medical Center Utrecht
sex or gender	male
ISNI	0000000460018149
VIAF ID	751149066712065601360
family name	Peters
WorldCat Identities ID (superseded)	viaf-751149066712065601360
ORCID iD	wds:Q40309011-74751B65-1871-4B76-9E7B-63D38F081967
ORCID iD	https://orcid.org/0000-0002-7981-5768
ORCID iD	0000-0002-7981-5768
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q40309011
is author of	Bedside teaching in medical education: a literature review. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for 125I prostate brachytherapy Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer. Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints Rectal dose constraints for salvage iodine-125 prostate brachytherapy Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer Salvage brachytherapy for radiorecurrent prostate cancer: Searching for safety and success. Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy. Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer Who can do without patients? Reply to: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. Hamdy et al. NEJM October 2016. Erratum to: Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review.
is author of	wds:Q40369415-86E0B722-DBFD-41E8-9C0C-986B087E98C9 wds:Q60920500-C828795F-2C5C-400D-A433-FE98B12648AE wds:Q88232353-3444468F-32CB-4415-B78C-EC1881C2BDF4 wds:Q38035794-679685BB-0CB8-436A-95F1-5621C4FEC22A wds:Q43512897-E6CA88D6-62FC-42A1-AFEB-435EDA78FF25 wds:Q50053055-4FD6CC89-35B3-4329-9CE1-BF3178091D78 wds:Q40308955-731DADEE-64F5-4542-B63E-24EAA44B1848 wds:Q98568606-05BC79BF-A156-48B8-97BC-7D58D08057FA wds:Q38978887-BA166895-0F28-457C-90EC-9B7C4966DCD0 wds:Q39943901-9EA6014E-259C-4D74-822D-72ED4C8040B5 wds:Q86090729-08CA7646-60D2-4EFE-8D5D-A81D46BB5712 wds:Q92342081-DB389BB7-3758-43E6-A30F-356B9B3076E2 wds:Q112293391-A9F8CF57-6431-43C0-AB59-D5235D47E93A wds:Q39981995-AB4B1E67-AFDB-4A7C-9198-CA2038CBAEEF wds:Q39823842-2F4E3D2A-4EC7-454D-9C6F-E4DD37FCB2F3 wds:Q48225247-06E216B4-AC4F-4456-A8C0-FA88A62DFD36 wds:Q35969717-A60EE8E8-027F-45C5-8A72-5BAE69357C4A wds:Q34992134-8FE33F61-B648-4E3C-A43B-09830A582795 wds:Q48131290-CA685223-66B3-43FC-A8C0-55E1D33748E5 wds:Q86822631-761FA7A2-400E-492E-8A5D-1F4584DF37ED

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software